SEC Form 4 · accession 0001415889-17-001429
Niagen Bioscience, Inc. · NAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen R. Allen
Director
Period of report
Aug 25, 2017
Accepted (ET)
Aug 28, 2017 · 8:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386570
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 25, 2017 | P | 2,000 | $3.31 | A | 7,000 | D |
Table II — derivative securities
No Table II lines on this filing.